Video

BioTissue continues the rollout of its corporate rebranding

Author(s):

Kassi Jackson
Conferences|ASCRS

Earlier this year, BioTissue announced the corporate rebrand of its new customer facing entity, including carrying the name over to its surgical business formally known as Amniox Medical. Randy Mansfield, VP of marketing for BioTissue, shares an update at ASCRS 2022.

Related Videos
Ophthalmology Times: Kathryn Colby, MD, PhD, reflects on National Women Physicians Day
Image credit: ©Ophthalmology Times
Wendy Lee, MD, talks about functional oculoplastics and aesthetics at EnVision Summit 2025
Lana Rifkin, MD, uveitis committee chair at EnVision Summit 2025
Related Content
(Image credit: AdobeStock/Deemerwha studio)
January 27th 2025

The path forward for oculomics and AI

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

4DMT publishes preclinical data demonstrating the potential of the Therapeutic Vector Evolution (TVE) platform
December 20th 2024

4DMT publishes preclinical data demonstrating the potential of the Therapeutic Vector Evolution (TVE) platform

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Generative AI: It’s only just begun
December 9th 2024

Generative AI: It’s only just begun

Binocular amblyopia home treatment: The next step after patching
November 19th 2024

Binocular amblyopia home treatment: The next step after patching

© 2025 MJH Life Sciences

All rights reserved.